Adverse events should be reported to Gilead safety and to your national reporting system. This promotional meeting is organised and fully funded by Gilead Sciences Europe Ltd.
Gilead medicines will be discussed.
CONFIDENTIAL
Please do not distribute, intended for HCPs only.
Full prescribing information available at https://www.emcpi.com/pi/ni/423
Date of preparation: March 2022 IHQ-RDV-0227
|